论文部分内容阅读
本文探讨癌症疼痛病人接受盐酸吗啡缓释片治疗的效果及其安全性。全国 13个省市 2 5家医院参加此项多中心开放性临床试验 ,共 5 6 7例癌症疼痛病人接受盐酸吗啡缓释片镇痛治疗 ,平均年龄 5 7.8岁 (16～ 91岁 )。结果显示镇痛疗效 :治疗前病人疼痛程度 (NRS)为 7.0± 1.8,其中重
This article investigates the efficacy and safety of morphine hydrochloride sustained-release tablets in patients with cancer pain. A total of 567 cancer pain patients underwent analgesia with morphine hydrochloride sustained-release tablets, with an average age of 5 7.8 years (range, 16 to 91 years). Twenty-five hospitals in 13 provinces and cities nationwide participated in the multicenter open-label clinical trial. The results showed that analgesic efficacy: before treatment, the patient’s pain level (NRS) was 7.0 ± 1.8, of which weight